Amgen, Teva Cut Illegal Deal To Pull Generic, Suit Says
Amgen struck an illegal deal with Teva Pharmaceuticals to pull a generic version of the calcium control drug Sensipar from the market after it had already netted $59 million in profits,...To view the full article, register now.
Already a subscriber? Click here to view full article